Quest Diagnostics/DGX

$138.36

0.12%
-
1D1W1MYTD1YMAX

About Quest Diagnostics

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It provides diagnostic information services for infectious diseases, such as tuberculosis (e.g., T.SPOT.TB and Quantiferon offerings) and tick-borne disease (e.g., Accutix offering). Its comprehensive offerings in drug monitoring and toxicology, in neurology diagnostics, in advanced cardiovascular diagnostic information services (e.g. CARDIO IQ and Cleveland HeartLab offerings through its Cardiometabolic Center of Excellence), and in cancer diagnostics. Its Diagnostic Solutions business consists of its risk assessment services and healthcare information technology businesses. Its risk assessment service, ExamOne, is a provider of risk assessment services for the life insurance industry in North America.

Ticker

DGX

Sector

Healthcare

Trading on

NYSE

Industry

Healthcare Facilities

CEO

James Davis

Employees

40,000

Headquarters

Secaucus, United States

DGX Metrics

BasicAdvanced
$15B
Market cap
18.69
P/E ratio
$7.43
EPS
0.88
Beta
$2.84
Dividend rate
2.16%
Dividend yield
$15B
0.88326
$145.62
$119.59
962K
$2.84
0.97
0.891
59.142
73.228
37.77%
32.218
8.4%
6.51%
13.49%
7.61%
18.693
1.662
2.397
24.573
1.75%
2.04%
2.16%
-3.29%
9.81%
-0.66%
-10.46%
8.08%

What the Analysts think about DGX

Analyst Ratings

Majority rating from 18 analysts.
Hold

Price Targets

Average projection from 14 analysts.
6.3% upside
High $160.00
Low $136.00
$138.36
Current price
$147.07
Average price target

DGX Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
8.19% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$2.4B
3.41%
Net income
$194M
1.04%
Profit margin
8.19%
-2.38%

DGX Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 9.95%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$2.30
$2.22
$2.15
$2.04
-
Expected
$2.27
$2.19
$2.11
$1.86
$2.34
Surprise
1.48%
1.41%
1.7%
9.95%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Quest Diagnostics stock?

Quest Diagnostics (DGX) has a market cap of $15B as of May 30, 2024.

What is the P/E ratio for Quest Diagnostics stock?

The price to earnings (P/E) ratio for Quest Diagnostics (DGX) stock is 18.69 as of May 30, 2024.

Does Quest Diagnostics stock pay dividends?

Yes, the Quest Diagnostics (DGX) stock pays dividends to shareholders. As of May 30, 2024, the dividend rate is $2.84 and the yield is 2.16%. Quest Diagnostics has a payout ratio of 37.77% on a trailing twelve-month basis.

When is the next Quest Diagnostics dividend payment date?

The next Quest Diagnostics (DGX) dividend payment is scheduled for July 22, 2024.

What is the beta indicator for Quest Diagnostics?

Quest Diagnostics (DGX) has a beta rating of 0.88. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Quest Diagnostics stock price target?

The target price for Quest Diagnostics (DGX) stock is $147.07, which is 6.3% above the current price of $138.36. This is an average based on projections from 14 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Quest Diagnostics stock

Buy or sell Quest Diagnostics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing